Rate My Professor Gemella Reynolds-Hatem

The project entails testing the drugs capivasertib and fulvestrant to inhibit tumour growth in CDH1-associated cancer models, alongside community wānanga at Tuahiwi that incorporate tikanga Māori practices to improve health outcomes for affected whānau. Her research seeks to integrate mātauranga Māori into scientific processes, advocate for addressing mamae in healthcare and research settings, and enhance the responsiveness of health systems to Māori needs. Motivated by a tuakana's revelation during her undergraduate studies about the CDH1 mutation's prevalence in her iwi, she perceives this work as a calling to serve her people. Reynolds-Hatem also holds the position of Tumuaki Takirua (Co-President) of Te Rōpū Māori, where she leads advocacy for Māori students, delivers kōrero at events such as the opening of new cancer research facilities, and contributes to fostering Māori success in science. Guided by the whakataukī "Mō tātou, ā, mō kā uri ā muri ake nei" (For us and our children after us), her endeavors aim to create enduring benefits for present and future generations.